These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3402540)
1. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors. Janowsky A; De Paulis T; Clanton JA; Smith HE; Ebert MH; Kessler RM Eur J Pharmacol; 1988 May; 150(1-2):203-5. PubMed ID: 3402540 [No Abstract] [Full Text] [Related]
2. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917 [TBL] [Abstract][Full Text] [Related]
3. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Hall H; Wedel I Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136 [TBL] [Abstract][Full Text] [Related]
4. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. Lazareno S; Nahorski SR Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377 [TBL] [Abstract][Full Text] [Related]
5. [125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor. Sánchez-Roa PM; Grigoriadis DE; Wilson AA; Sharkey J; Dannals RF; Villemagne VL; Wong DF; Wagner HN; Kuhar MJ Life Sci; 1989; 45(19):1821-9. PubMed ID: 2531826 [TBL] [Abstract][Full Text] [Related]
6. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. Kessler RM; Ansari MS; de Paulis T; Schmidt DE; Clanton JA; Smith HE; Manning RG; Gillespie D; Ebert MH J Nucl Med; 1991 Aug; 32(8):1593-600. PubMed ID: 1831229 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand. Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide. Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245 [TBL] [Abstract][Full Text] [Related]
10. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes. Kilpatrick GJ; Jenner P; Marsden CD Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599 [TBL] [Abstract][Full Text] [Related]
11. [125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum. Kilpatrick GJ; Jenner P; Marsden CD J Pharm Pharmacol; 1986 May; 38(5):406-8. PubMed ID: 2423678 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes. Arima T; Samura N; Nomura Y; Segawa T Jpn J Pharmacol; 1986 Jul; 41(3):419-23. PubMed ID: 3761757 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents. Murphy RA; Kung HF; Kung MP; Billings J J Med Chem; 1990 Jan; 33(1):171-8. PubMed ID: 2136916 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives. Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520 [TBL] [Abstract][Full Text] [Related]
15. Radioiodinated 2'-iodospiperone: a new radioligand for in vivo dopamine receptor study. Saji H; Nakatsuka I; Shiba K; Tokui T; Horiuchi K; Yoshitake A; Torizuka K; Yokoyama A Life Sci; 1987 Oct; 41(17):1999-2006. PubMed ID: 3669906 [TBL] [Abstract][Full Text] [Related]
16. Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS. Leff SE; Chen A; Creese I Neuropharmacology; 1984 May; 23(5):589-90. PubMed ID: 6738827 [TBL] [Abstract][Full Text] [Related]
17. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. Terai M; Hidaka K; Nakamura Y Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228 [TBL] [Abstract][Full Text] [Related]
19. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand. Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666 [TBL] [Abstract][Full Text] [Related]
20. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum. Oki K; Nomura Y Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]